Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies
Cancer therapy increasingly relies on a personalised approach, where genetic changes in an individual tumour…
Race, gender and the ways these identities intersect matter in cancer outcomes
By Timothy Pawlik, The Ohio State University; Elizabeth Palmer, The Ohio State University, and Samilia…
Genetic “hotspots” could point to new cancer treatment strategies
Many cancers contain similar genetic “hotspots” — areas of DNA that are likely to be…
New study is a smoking gun, shows vaping is no deterrent to teen tobacco use
Kids who experiment with e-cigarettes end up smoking tobacco about as much as teen smokers who never used the devices,…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.